SynthesisFrontiers in neuroscience2026
Association between blood neurofilament light chain levels and vascular cognitive impairment: a systematic review and meta-analysis.
Synthesis in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Vascular cognitive impairment (VCI) is the second leading cause of cognitive impairment after Alzheimer's disease, primarily associated with vascular risk factors and cerebrovascular disease. Advances in ultra-low concentration single-molecule array (Simoa) technology have enabled the quantitative monitoring of blood neurofilament light chain (NfL) levels. Consequently, we performed a meta-analysis to evaluate the association between blood NfL levels in VCI. Methods: This meta-analysis was conducted in accordance with the PRISMA guidelines. We systematically searched PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), VIP Information (VIP), and Wanfang Data databases, with a search period extending from database inception to December 3, 2025. Two reviewers independently performed the literature selection, data extraction, and assessed the study quality using the Newcastle-Ottawa Scale (NOS). The weighted mean difference (WMD) and its 95% confidence interval (CI) were used to combine effect sizes. Heterogeneity was evaluated utilizing the Chi-square ( Results: This systematic review included 13 studies, comprising 3,716 patients. The meta-analysis results indicated that blood NfL levels in VCI patients were significantly higher than those in the non-VCI group (WMD = 15.06, 95% CI = [11.41, 18.71], Conclusion: Our results suggest that blood NfL levels are significantly higher in VCI patients compared to non-VCI patients, indicating a strong association between blood NfL and VCI. This supports its potential as a discriminative biomarker for VCI. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD420251240858.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.